Linii Celulare Umane

NCH690, Human Stem Cell Like Glioma cell line, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of usage from distributor.

NCH644, Human Stem Cell Like Glioma cell line, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of usage from distributor.

NCH612, Human Anaplastic Oligodendroglioma cell line, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of usage from distributor.

NCH421K, Human Stem Cell Like Glioma cell line, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of usage from distributor.

2427T, Lung tumor cells, primary tumor, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of usage from distributor.

2106LN, Lung tumor cells, lymph node metstasis, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of usage from distributor.

2106T, Lung tumor cells, primary tumor, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of usage from distributor.

HK-2xZFN-mEGFP-Nup107, EGFP-Nup107 stably transfected in HeLa Kyoto cells, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of usage from distributor.

HeLa Kyoto LaminA EGFP/H2B-mCherry, EGFP-LaminA/H2B-mCherry stably transfected in HeLa Kyoto cells, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of

HeLa Kyoto Mad2-LAP /H2B-mCherry, , cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of usage from distributor.

HeLa Kyoto EGFP-Lamin B1/H2B-mCherry, EGFP-Lamin B1/H2B-mCherry stably transfected in HeLa Kyoto cells, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration

HeLa Kyoto Cap-D2 EGFP, EGFP CAP-D2 stably expressed in HeLa Kyoto, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of usage from distributor.

HeLa Kyoto Kleisin-beta EGFP, EGFP-Kleisin-beta stably expressed in HeLa Kyoto cells, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of usage from dis

HeLa Kyoto H2B EGFP, H2B EGFP stably expressed in HeLa Kyoto cells, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of usage from distributor.

HeLa Kyoto EGFP alpha-tubulin/H2B-mCherry, alpha-tubulin/H2B m-Cherry EGFP stably expressed in HeLa Kyoto cells, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a de

HeLa Kyoto EB3 EGFP, EGFP EB3 stably expressed in HeLa Kyoto cells, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of usage from distributor.

HNO258, Human HNSCC cell line, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of usage from distributor.

HNO223, Human HNSCC cell line, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of usage from distributor.

HNO210, Human HNSCC cell line, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of usage from distributor.

HNO97, Human HNSCC cell line, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of usage from distributor.

HNO41, Human HNSCC cell line, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of usage from distributor.

HaCaT, Human keratinocyte cell line, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of usage from distributor.

HaCaT, Human keratinocyte cell line, cryopreserved in CM-2, cryovial. The customer (not-for-profit) must sign an MTA. These cells MUST NOT not be forwarded to for-profit customers. CLS needs a declaration of usage from distributor.

HROHep03, Human Hepatoma cell lineman, cryovial

HROGas03, Human Gastric carcinoma cell line, cryovial

HROG36, Human Glioblastoma cell line, cryovial

HROG17, Human Glioblastoma cell line, cryovial

HROG15, Human Glioblastoma cell line, cryovial

HROG13, Human Glioblastoma cell line, cryovial

HROG10, Human Glioblastoma cell line, cryovial

HROG07, Human Glioblastoma cell line, cryovial

HROG06, Human Glioblastoma cell line, cryovial

HROG05, Human Glioblastoma cell line, cryovial

HROG04, Human Glioblastoma cell line, cryovial

HROG02, Human Glioblastoma cell line, cryovial

Bc HROC313, Human B lymphocyte cell line, EBV-transformed, cryovial

Bc HROC277, Human B lymphocyte cell line, EBV-transformed, cryovial

Bc HROC257, Human B lymphocyte cell line, EBV-transformed, cryovial

Bc HROC183, Human B lymphocyte cell line, EBV-transformed, cryovial

Bc HROC69, Human B lymphocyte cell line, EBV-transformed, cryovial

Bc HROC39, Human B lymphocyte cell line, EBV-transformed, cryovial

Bc HROC32, Human B lymphocyte cell line, EBV-transformed, cryovial

Bc HROC24, Human B lymphocyte cell line, EBV-transformed, cryovial

HROC313Met1 T0 M2, Human Colorectal Adenocarcinoma cell line, from Xenograft, cryovial

HROC374, Human Colorectal Adenocarcinoma cell line, cryovial

HROC357, Human Colorectal Adenocarcinoma cell line, cryovial

HROC334, Human Colorectal Adenocarcinoma cell line, cryovial

HROC277Met2 T0 M1, Human Colorectal Adenocarcinoma cell line, from Xenograft, cryovial

HROC277Met2, Human Colorectal Adenocarcinoma cell line, from Metastasis, cryovial

HROC239 T0 M1, Human Colorectal Adenocarcinoma cell line, from Xenograft, cryovial

HROC112Met T0 M2, Human Colorectal Adenocarcinoma cell line, from Xenograft, cryovial

HROC107 cT0 M2, Human Colorectal Adenocarcinoma cell line, from Xenograft, cryovial

HHC6548 T1 M1, Human Colorectal Adenocarcinoma cell line, from Xenograft, cryovial

HROC87 T0 M2, Human Colorectal Adenocarcinoma cell line, from Xenograft, cryovial

HROC80 T1 M1, Human Colorectal Adenocarcinoma cell line, from Xenograft, cryovial

HROC69 T0 M2, Human Colorectal Adenocarcinoma cell line, from Xenograft, cryovial

HROC69, Human Colorectal Adenocarcinoma cell line, cryovial

HROC60, Human Colorectal Adenocarcinoma cell line, cryovial

HROC59 T1 M1, Human Colorectal Adenocarcinoma cell line, from Xenograft, cryovial

HROC57, Human Colorectal Adenocarcinoma cell line, cryovial

HROC46 T0 M1 #13, Human Colorectal Adenocarcinoma cell line, from Xenograft, cryovial

HROC43, Human Colorectal Adenocarcinoma cell line, cryovial

HROC40, Human Colorectal Adenocarcinoma cell line, cryovial

HROC39 T0 M2, Human Colorectal Adenocarcinoma cell line, from Xenograft, cryovial

HROC39, Human Colorectal Adenocarcinoma cell line, cryovial

HROC32 T3 M1, Human Colorectal Adenocarcinoma cell line, from Xenograft, cryovial

HROC32, Human Colorectal Adenocarcinoma cell line, cryovial

HROC285Met, Human Colorectal Adenocarcinoma cell line, from Metastasis, cryovial

HROC284Met, Human Colorectal Adenocarcinoma cell line, from Metastasis, cryovial

HROC257 T0 M1, Human Colorectal Adenocarcinoma cell line, from Xenograft, cryovial

HROC257, Human Colorectal Adenocarcinoma cell line, cryovial

HROC24 T1 M1, Human Colorectal Adenocarcinoma cell line, from Xenograft, cryovial

HROC24, Human Colorectal Adenocarcinoma cell line, cryovial

HROC212, Human Colorectal Adenocarcinoma cell line, cryovial

HROC183 T0 M2, Human Colorectal Adenocarcinoma cell line, from Xenograft, cryovial

HROC183, Human Colorectal Adenocarcinoma cell line, cryovial

HROC18, Human Colorectal Adenocarcinoma cell line, cryovial

HROC173, Human Colorectal Adenocarcinoma cell line, cryovial

HROC147Met, Human Colorectal Adenocarcinoma cell line, from Metastasis, cryovial

HROC131 T0 M3, Human Colorectal Adenocarcinoma cell line, from Xenograft, cryovial

HROC126, Human Colorectal Adenocarcinoma cell line, cryovial

HROC113 cT0 M1, Human Colorectal Adenocarcinoma cell line, from Xenograft, cryovial

HROC103Met, Human Colorectal Adenocarcinoma cell line, from Metastasis, cryovial

HROC103 T0 M1, Human Colorectal Adenocarcinoma cell line, from Xenograft, cryovial

HROBML03, Human non-small cell Lung cancer (NSCLC) cell line, cryovial

HROBMC01, Human Colorectal Adenocarcinoma cell line, cryovial

HHC6548 T1 M1, Human Colorectal Adenocarcinoma cell line, cryovial

ZR-75-1, Human breast carcinoma cell line, 2xT25

WT-CLS1, Human kidney (Wilm's Tumor) cell line, 2xT25

WiDr, Human Colon adenocarcinoma cell line, 2xT25

TK6, Human Spleen lymphoblast cell line, 2xT25

TF-1, Human Bone marrow Erythroleukemia cell line, 1xT25

T84, Human Colon carcinoma cell line, 2xT25

SW-1736, Human Thyroidea carcinoma cell line, 2xT25

SW-1353, Human Bone chondrosarcoma cell line, 2xT25

SW-1116, Human Colon adenocarcinoma (G III) cell line, 2xT25

SV-80, Human Lung fibroblast (SV40-transformed), 2xT25

SCLC-22H, Human Lung small cell carcinoma cell line, 1xT25

SCLC-21H, Human Lung small cell carcinoma cell line, 1xT25

RPMI-2650, Human Nasal squamous cell carcinoma cell line, 2xT25